Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for painless electronic bronchoscopy
ChiCTR2500115045Phase 4Not yet recruiting
- Sponsor
- Zunyi Medical University Affiliated Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine in bronchopulmonary diseases (2 arms), sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoints: Incidence of respiratory depression and Adverse events. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2500115045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115045.